FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37765311000001105: Rizmoic 200microgram tablets (Shionogi BV) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1706871000001116 Rizmoic 200microgram tablets (Shionogi BV) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1706881000001119 Rizmoic 200microgram tablets (Shionogi BV) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizmoic 200microgram tablets (Shionogi BV) Is a Naldemedine 200microgram tablets true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Is a Rizmoic true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naldemedine true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has specific active ingredient Naldemedine tosylate true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rizmoic 200microgram tablets (Shionogi BV) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rizmoic 200microgram tablets (Shionogi BV) 28 tablet 2 x 14 tablets Has AMP True Rizmoic 200microgram tablets (Shionogi BV) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start